Efficacy and Safety of 14-day Concomitant Therapy for Refractory Helicobacter Pylori Infection

Clinical trial NCT05133193 · UNKNOWN

Trial details

NCT number: NCT05133193
Sponsor: Shandong University
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Helicobacter Pylori Infection

Start date: 2021-11-20
Primary completion: 2022-06-30
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.